BMS-919373
- Generic Name
- BMS-919373
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H20N6O2S
- CAS Number
- 1272353-82-8
- Unique Ingredient Identifier
- NGB50MQK8N
- Background
BMS-919373 is under investigation in clinical trial NCT02153437 (Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers).
- Associated Conditions
- -
- Associated Therapies
- -
A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 158
- Registration Number
- NCT02156076
- Locations
- 🇺🇸
Wcct Global, Llc, Costa Mesa, California, United States
🇺🇸Long Beach Va Medical Center, Long Beach, California, United States
🇺🇸Community Clinical Research Center, Anderson, Indiana, United States
Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2014-06-03
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 7
- Registration Number
- NCT02153437
- Locations
- 🇨🇦
Local Institution - 0001, Toronto, Ontario, Canada
🇨🇦Local Institution, Montreal, Quebec, Canada
🇨🇦The University Of Calgary, Calgary, Alberta, Canada
Drug Interaction Statin
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2014-08-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 26
- Registration Number
- NCT02089061
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath